Back
Sofgen Pharma SA 10K Form
Sell
39
PROCF
Sofgen Pharma SA
Last Price:
$0.05
Seasonality Move:
-12.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PROCF News And Ratings
See the #1 stock for the next 7 days that we like better than PROCF
PROCF Financial Statistics
Sales & Book Value
| Annual Sales: | $423.7M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0.13 |
| Annual Sales: | $0.00 |
| Price / Book: | 549.06 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $238M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Sofgen Pharma SA Earnings Forecast
Key Sofgen Pharma SA Financial Ratios
-
The Gross Profit Margin over the past 4 years for PROCF is 56.16%.
-
The Selling, General & Administrative Expenses for PROCF have been equal to 45.63% of Gross Profit Margin.
-
The Interest Expense is 113.64% of Operating Income.
-
The Net Earning history of PROCF is 9.52% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 2 years.
Sofgen Pharma SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PROCF |
| Website: | procapsgroup.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.13 |
|---|---|
| Forward P/E Ratio: | 0 |
PROCF Technical Analysis vs Fundamental Analysis
Sell
39
Sofgen Pharma SA (PROCF)
is a Sell
Is Sofgen Pharma SA a Buy or a Sell?
-
Sofgen Pharma SA stock is rated a SellThe current Sofgen Pharma SA [PROCF] share price is $0.05. The Score for PROCF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.